About
Ganga Pharmaceuticals Limited manufactures, markets, and distributes ayurvedic medicines in India. The company was incorporated in 1989 and is based in Mumbai, India.
Quarterly Results
No quarterly results synced yet for this stock.
Data is backfilled from screener.in — check back soon.Profit & Loss
Annual · Rs. Crores| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2.83 | 2.48 | 2.58 | 2.47 | 2.32 | 2.27 | 2.99 | 3.18 | 2.73 | 2.63 | 2.45 | 2.44 |
| Expenses | 2.79 | 2.60 | 2.53 | 2.47 | 2.28 | 2.24 | 2.61 | 2.76 | 2.41 | 2.32 | 2.15 | 2.19 |
| Operating Profit | 0.04 | -0.12 | 0.05 | 0.00 | 0.04 | 0.03 | 0.38 | 0.42 | 0.32 | 0.31 | 0.30 | 0.25 |
| OPM % | 1.41 | -4.84 | 1.94 | 0.00 | 1.72 | 1.32 | 12.71 | 13.21 | 11.72 | 11.79 | 12.24 | 10.25 |
| Other Income | 0.28 | 0.44 | 0.24 | 0.30 | 0.26 | 0.25 | 0.17 | 0.14 | 0.15 | 0.16 | 0.14 | 0.17 |
| Interest | 0.13 | 0.18 | 0.18 | 0.19 | 0.19 | 0.19 | 0.24 | 0.25 | 0.28 | 0.32 | 0.33 | 0.33 |
| Depreciation | 0.06 | 0.05 | 0.05 | 0.06 | 0.05 | 0.05 | 0.05 | 0.05 | 0.06 | 0.04 | 0.04 | 0.04 |
| Profit before tax | 0.13 | 0.09 | 0.06 | 0.05 | 0.06 | 0.04 | 0.26 | 0.26 | 0.13 | 0.11 | 0.07 | 0.05 |
| Tax % | 23.08 | 11.11 | 33.33 | 40.00 | 16.67 | 50.00 | 23.08 | 30.77 | 23.08 | 27.27 | 28.57 | 40.00 |
| Net Profit | 0.10 | 0.08 | 0.05 | 0.04 | 0.04 | 0.02 | 0.19 | 0.19 | 0.09 | 0.07 | 0.05 | 0.03 |
| EPS in Rs | 0.17 | 0.17 | 0.10 | 0.10 | 0.10 | 0.05 | 0.47 | 0.47 | 0.22 | 0.17 | 0.12 | 0.13 |
| Dividend Payout % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Balance Sheet
Annual · Rs. Crores — latest first| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 5.91 | 4.84 | 4.84 | 4.06 | 4.06 | 4.06 | 4.06 | 4.06 | 4.06 | 4.06 | 4.06 | 2.33 |
| Reserves | 2.40 | 2.29 | 2.21 | 1.39 | 1.35 | 1.31 | 1.29 | 1.09 | 0.91 | 0.81 | 0.74 | 0.31 |
| Borrowings | 1.09 | 1.42 | 1.36 | 1.83 | 1.93 | 1.73 | 1.47 | 1.87 | 2.05 | 2.14 | 2.19 | 2.14 |
| Other Liabilities | 0.25 | 0.42 | 0.24 | 0.71 | 0.66 | 0.56 | 0.75 | 0.74 | 1.22 | 0.60 | 0.35 | 0.61 |
| Total Liabilities | 9.65 | 8.97 | 8.65 | 7.99 | 8.00 | 7.66 | 7.57 | 7.76 | 8.24 | 7.61 | 7.34 | 5.39 |
| Fixed Assets | 0.65 | 0.66 | 0.61 | 0.64 | 0.68 | 0.72 | 0.76 | 0.80 | 0.82 | 0.62 | 0.62 | 0.65 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.09 | 0.09 | 0.09 | 0.09 | 0.09 | 0.09 | 0.00 | 0.00 | 0.50 | 0.05 |
| Other Assets | 9.00 | 8.31 | 7.95 | 7.26 | 7.23 | 6.85 | 6.72 | 6.87 | 7.42 | 6.99 | 6.22 | 4.69 |
| Total Assets | 9.65 | 8.97 | 8.65 | 7.99 | 8.00 | 7.66 | 7.57 | 7.76 | 8.24 | 7.61 | 7.34 | 5.39 |
Cash Flows
Annual · Rs. Crores — latest first| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | -1.31 | -0.58 | -1.26 | -0.04 | -0.21 | -0.18 | -0.31 | 0.11 | 0.24 | 0.05 | -1.05 | 0.27 |
| Cash from Investing Activity | 0.24 | 1.18 | 0.13 | 0.49 | 0.19 | 0.28 | 0.37 | 0.28 | -0.14 | 0.62 | -0.83 | -0.18 |
| Cash from Financing Activity | 0.82 | -0.33 | 1.14 | -0.44 | 0.03 | -0.10 | -0.29 | -0.45 | -0.36 | -0.33 | 1.90 | -0.06 |
| Net Cash Flow | -0.24 | 0.27 | 0.00 | 0.01 | 0.01 | 0.00 | -0.22 | -0.05 | -0.26 | 0.33 | 0.02 | 0.03 |
| Free Cash Flow | -1.35 | -0.68 | -1.28 | -0.05 | -0.22 | -0.20 | -0.32 | 0.08 | -0.02 | 0.01 | -1.06 | 0.23 |
| CFO/OP % | -3,200.00 | 475.00 | -2,480.00 | — | -500.00 | -567.00 | -66.00 | 40.00 | 88.00 | 29.00 | -347.00 | 104.00 |
Ratios
Annual · Days / % — latest first| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 121.24 | 133.93 | 130.16 | 131.52 | 140.02 | 131.85 | 130.62 | 141.18 | 211.25 | 173.48 | 140.04 | 109.20 |
| Inventory Days | 328.50 | 353.03 | 362.08 | 347.34 | 330.51 | 332.62 | 296.56 | 341.26 | 358.71 | 385.66 | 374.86 | 288.16 |
| Days Payable | 33.69 | 83.77 | 29.20 | 170.73 | 152.32 | 129.52 | 159.69 | 163.21 | 330.39 | 182.50 | 98.65 | 118.01 |
| Cash Conversion Cycle | 416.04 | 403.19 | 463.04 | 308.13 | 318.21 | 334.96 | 267.49 | 319.23 | 239.56 | 376.64 | 416.26 | 279.35 |
| Working Capital Days | 807.39 | 731.47 | 639.46 | 477.31 | 503.45 | 477.56 | 449.23 | 387.96 | 417.14 | 428.84 | 467.80 | 142.11 |
| ROCE % | 2.90 | 3.18 | 3.06 | 3.28 | 3.46 | 3.30 | 7.23 | 7.26 | 5.84 | 6.14 | 6.80 | 8.03 |
Corporate Actions
No corporate actions recorded.